Stocks and Investing
Stocks and Investing
Tue, May 14, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Patrick Trucchio Reiterated (ALT) at Strong Buy and Held Target at $12 on, May 14th, 2024
Patrick Trucchio of HC Wainwright & Co., Reiterated "Altimmune, Inc." (ALT) at Strong Buy and Held Target at $12 on, May 14th, 2024.
Patrick has made no other calls on ALT in the last 4 months.
There are 4 other peers that have a rating on ALT. Out of the 4 peers that are also analyzing ALT, 2 agree with Patrick's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Seamus Fernandez of "Guggenheim" Downgraded from Strong Buy to Hold on, Monday, April 29th, 2024
- Corinne Jenkins of "Goldman Sachs" Initiated at Hold and Held Target at $13 on, Wednesday, January 24th, 2024
These are the ratings of the 2 analyists that currently disagree with Patrick
- Jonathan Wolleben of "JMP Securities" Maintained at Buy with Decreased Target to $24 on, Friday, May 10th, 2024
- Mayank Mamtani of "B. Riley Securities" Reiterated at Strong Buy and Held Target at $20 on, Thursday, March 28th, 2024
Contributing Sources